News

We are celebrating yet another Holiday Season with festivities in many cultures all around the world. It is, therefore, a special time of the year for many of us. For many people and very often for organizations, it is also the time to reflect on the past year and our...

On October 31st, we announced that PD-value is among the FD Gazellen this year. Last Thursday, Het Financieele Dagblad announced that we ranked 12th among the SMEs in the East region and 84th among the 1003 Gazellen, the fastest-growing companies, in the Netherlands....

We are happy to announce that PD-value is one of “FD Gazellen” this year! FD Gazellen is awarded by “Het Financieele Dagblad”, a Dutch Financial Newspaper, to the fast-growing Dutch Companies. We are honored to be among the selected group. We will continue to put our...

We are happy to announce that PD-value has officially become a member of MabDesigntheFrench biotherapy industry association. This partnership signifies our unwaveringcommitment to the region and our dedication to fostering growth and collaboration withinour industry....

It is the Holiday Season with festivities and celebrations in many cultures all around the world. No wonder why it is such a special time of the year. It is also the time to reflect on the past year and our experiences. It has been a year with many challenges around...

If you are following me on LinkedIn, you might have seen my journeys for attending Systems Biology conferences. After such a long period of limited interaction, I felt like reconnecting and catching up with the scientific community was what I needed. And I was in for...

In my last blog, I wrote that I will, specifically, focus on dosing in two blogs, and this one will finalize our mini-series, if you will, on dosing, at least for now. The first post focused more on the technical aspect of the topic, whereas now we will talk about the...

We continue to explore the opportunities opening up with the systems approaches in drug development in our blog series. The next two blogs will be specifically dedicated to dosing as it is a crucial aspect of drug development, and recently we have seen some...

In 2017, the FDA designed the Model Informed Drug Development (MIDD)1 Program to have a platform where the FDA and drug developers can discuss model-based approaches in drug and medical products development. In addition, the program aims to identify the best MIDD...

Systems Pharmacology or Quantitative Systems Pharmacology (QSP) is the field where systems biology approaches are explicitly applied to pharmacology. It is, in a way, an intersection between pharmacometrics and systems biology. The aim is to understand how a ‘system’...